The Hindu Business Line : Sunday, June 08, 2003

Incentive row: N-E States back industry
THE State Governments of the North-Eastern (N-E) region see merit in the objections raised by the industry to the extension of a substantial part of the incentive package, devised by New Delhi exclusively for the region in late 1997, to Jammu & ... More

Knowledge must lead to economic growth: Kalam
EDUCATIONISTS, particularly the Vice-Chancellors and Principals of various institutes, had a different experience on Saturday with the President, Dr A.P.J. Abdul Kalam, asking them questions and eliciting answers. At an interactive session with ... More

Ministry to frame new norms for overseas aid
IN view of the Government's decision to reduce bilateral aid flows, the Finance Ministry will be framing a new set of guidelines that will govern future bilateral flows to India. According to an official release, the Finance Secretary, Mr S. ... More

FERTILISERS

Delayed rains hit four PSU fertiliser stocks
THE delayed monsoon has hit the fertiliser stocks badly. The four public sector fertiliser companies lined up by the Government for disinvestment have suffered a loss in valuation ranging between four and 12 per cent during the week even as the ... More

PETROLEUM

Why oil stocks are slippery
PASSION, unlike love, is a fleeting thing really. It passes with the moment. And when it passes, the object of passion is left forgotten. And so it could be with oil stocks, which are the latest passion for a ... More

PHARMACEUTICALS

Pharmaceuticals: A growth prescription
CAN THE pharma sector in India continue to build on the momentum it has gained in developed markets in recent years and leave an indelible footprint in the global pharma marketplace? That is the key question ... More

2005: A defining year
COME January 1, 2005, and India would have made the transition from a country that recognises process patents to one that takes cognisance of product patents. Let us look at what changes are in store for the ... More

When legal battles are no bitter pill
IN THE US, litigation is the price a company pays to be in business. A couple of Indian companies, such as Dr. Reddy's Labs and Ranbaxy, have taken on MNCs giants (Eli Lilly and GlaxoSmithKline respectively) ... More

The generic opportunity
WITH patented drugs of a combined value of close to $40 billion expected to go off patent in the next few years in the US, Indian pharmaceutical companies must be slavering. With proven skills in chemistry ... More

The right medicines
Dr. Reddy's Labs: Buy
Cipla: Hold
Glaxo SmithKline Pharma: Buy
Aventis Pharma: Buy
Ranbaxy: Hold More

SSI

`Govt framing single law for SSI sector'
IN the light of complaints from the small-scale industry (SSI) sector regarding prevalence of a plethora of Acts and rules, the Government is in the process of framing a single law for the SSI units, according to Dr C.P. Thakur, Union Minister ... More

MEDICAL INSTITUTIONS & HOSPITALS

Kalam inaugurates hospital in Chittoor
THE President, Dr A.P.J. Abdul Kalam, inaugurated the PES Institute of Medical Sciences and Research (PESIMSER) in Chittoor on Friday, according to a press release. The 790-bed hospital is built on a 75-acre campus with a built-up area of ... More

DISINVESTMENT

Advisors being finalised for BPCL divestment — DSP Merrill Lynch, UBS Warburg, I-Sec in reckoning
THE Central Government is likely to appoint DSP Merrill Lynch and UBS Warburg in partnership with ICICI Securities as the global advisors for the disinvestment of state-owned oil major Bharat Petroleum Corporation Ltd (BPCL). The names of the ... More

SMALL SAVINGS

EPF rate: Count your blessings!
THE decision of the Central Board of Trustees to pay 9.0 per cent plus a bonus of 0.5 per cent on employee provident fund balances for 2003-04 must come as a pleasant surprise to EPF subscribers. This is 1.5 ... More

Comments & Letters to the Editor to: bleditor@thehindu.co.in
Subscribe to: Business Line